Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014677 · ClinicalTrials.gov registry record · Phase 2
NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme
A Phase 2 study, sponsored by Neurocrine Biosciences.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00014677: Completed Phase 2 study, sponsored by Neurocrine Biosciences.
NCT00014677 is a Phase 2 study that has completed, run by Neurocrine Biosciences. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014677, a Phase 2 study, has completed, sponsored by Neurocrine Biosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: NBI-3001 may be able to locate cancer cells and stop them from growing. This may be an effective treatment for glioblastoma multiforme. PURPOSE: Randomized phase II trial to compare different regimens of NBI-3001 followed by surgery to remove the tumor in treating patients who have glioblastoma multiforme.
Interventions
- PROCEDURE conventional surgery
- BIOLOGICAL interleukin-4 PE38KDEL cytotoxin
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-03 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
What the finished NCT00014677 record still lists
NCT00014677 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00014677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00014677 about?
NCT00014677 is a clinical study titled "NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme". RATIONALE: NBI-3001 may be able to locate cancer cells and stop them from growing. This may be an effective treatment for glioblastoma multiforme. PURPOSE: Randomized phase II trial to compare different regimens of NBI-3001 followed by surgery to remove the tumor in treating patients who have gliob...
What is the current status of trial NCT00014677?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-03. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00014677?
The interventions under investigation include: conventional surgery (PROCEDURE), interleukin-4 PE38KDEL cytotoxin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00014677?
This trial is sponsored by Neurocrine Biosciences, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia